Adult neuro syndromes Flashcards
Benign fasiculation syndromes
Benign fasciculation syndromes presents with fasciculations in multiple muscles without associated cramps or weakness. Neurologic examination and electrodiagnostic testing are necessary to ensure that the patient does not have motor neuron disease or cramp-fasciculation syndrome. Patients can improve with withdrawal of caffeinated substances or treatment to allay anxiety.
Type 1 Charcot-marie-tooth
The history and examination are consistent with type 1 Charcot-Marie-Tooth disease (CMT1), the most common form of CMT disease. CMT1 is an inherited autosomal dominant sensory and motor peripheral neuropathy with hypertrophic demyelinating pathology. The most commonly present genetic alterations are either duplications or point mutations on the PMP22 gene. Nerve conduction slowing with velocities less than 30 m/s is characteristic. The other gene alterations listed are associated with CMT2, an axonal CMT variant typically manifesting nerve conduction velocities faster than 40 m/s.
multifocal motor neuropathy
Painless asymmetric weakness is a classic presentation of motor neuron disease. In patients with no evidence of upper motor neuron involvement, a diagnosis of multifocal motor neuropathy (MMN) must be excluded. Partial motor conduction blocks are a diagnostic hallmark of MMN.
APO-e4
The APOE-4 gene located on chromosome 19 is associated with late-onset Alzheimer disease.
Presenilin 1, presenilin 2 and amyloid precursor protein
Presenilin 1, presenilin 2 and amyloid precursor protein are associated with early-onset Alzheimer disease.
tau
The protein tau is encoded by MAPT and is implicated in the pathogenesis of frontotemporal dementia.
area postrema
An area postrema syndrome, characterized by intractable hiccups, nausea, and vomiting, occurs in up to 43 % of patients with Neuromyelitis Optica Spectrum Disorder.
Adult-onset polyglucosan body disease
Adult-onset polyglucosan body disease is a disorder typically presenting in the fifth to seventh decades of life. Patients present with gait difficulties with lower and upper motor neuron involvement and peripheral neuropathy, with sensory deficits predominantly in the lower extremities, neurogenic bladder, and dementia. The combination of lower and upper motor neuron signs with leukoencephalopathy should lead the clinician to suspect this entity.
dystonic reaction to reglan
Acute dystonic reactions are often observed after treatment with potent dopamine D2-receptor antagonists, including metoclopramide. Cervical and limb dystonia are most common. Laryngeal dystonia may be a life-threatening form of dystonic reaction in these patients. Anticholinergic medication, including diphenhydramine, is the most appropriate treatment.
recovery following stroke
Although the pattern of recovery following a stroke may be variable, the earliest evidence of a return of neurologic function is usually an increase in tone. This generally occurs before improvement in strength or a return of reflexes.
primary progressive aphasia
Primary progressive aphasia (PPA) is a frontotemporal dementia (frontotemporal degeneration, FTD) that is characterized initially by word-finding trouble, difficulty with naming, and comprehension. These language features are typically a dominant component of the disease in the first 2 years. Patients can later develop dysfunction in other domains, and late stage PPA patients may not appear that different from patients with other late stage dementias.
management of toxo
Because of the high likelihood of toxoplasmosis empiric antibiotic therapy with pyrimethamine and sulfadiazine is appropriate. If the patient improves after 2 weeks of therapy, the drugs should be continued for at least 6 weeks. If he fails to improve after 2 weeks, then brain biopsy should be considered to rule out other disorders.
MS drug to use during pregnancy
At this time glaterimer acetate is considered the safest agent to use during pregnancy and lactation. Ideally this individual should be transitioned to GA 1-2 months prior to conception.
Spinal bulbar muscular atrophy (Kennedy disease)
Spinal bulbar muscular atrophy (Kennedy disease) is characterized by lower motor neuron findings, especially affecting cranial musculature associated with decreased libido and gynecomastia. Female carriers are asymptomatic. Muscle biopsy shows nondiagnostic neuropathic changes. Testicular biopsy shows diminished spermatozoids with abnormal motility and mild elevation of FSH and LH. Diagnosis is by DNA analysis which shows expanded CAG repeats translated into polyglutamine repeats.
copper deficiency
This patient has subacute syndrome of pyramidal tract and dorsal column impairment due to copper deficiency. Alpha-tocopherol transfer protein gene mutation would present typically in childhood with gradual onset. A complete blood count might be abnormal, but not diagnostic. MRI of the spine might show increased T2 signal in the dorsal columns in several acquired nutritional deficiencies, but may be normal. Copper deficiency should be considered in patients with myelopathy following gastric surgery, or after zinc overdose.
abscess v tumor on DWI/ADC
Cerebral abscess can be distinguished from recurrent tumor based on differences in diffusion weighted imaging and ADC maps. Both demonstrate a ring-enhancing mass with surrounding T2 hyperintensity representing brain edema. Abscesses are characterized by marked hyperintensity on DWI in the cavity and corresponding hypointensity on ADC imaging. The opposite pattern is seen with recurrent tumor.
dopa-responsive dystonia
Dopa-responsive dystonia (DRD) presents in childhood as a progressive dystonia in children without a history of cerebral palsy or cognitive delay. It typically starts in a foot and progresses to become generalized. The most common inheritance pattern is autosomal dominant. The disease is unique for its robust and sustained response to low doses of levodopa. Its most notable characteristic is a diurnal variation, with symptoms usually more severe towards the end of the day and improved in the morning.
Isoniazid neurologic side effect
Isoniazid (INH), used in treatment of tuberculosis, depletes pyridoxine by increasing its excretion in urine. It can produce a predominantly sensory axonal neuropathy which is largely preventable with co-administration of vitamin B6 (pyridoxine).
cisplatin neurologic side effect
Cisplastin, a chemotherapeutic agent in common use for solid organ cancers, binds to and injures DNA, causing a sensory neuronopathy. There is no known preventative treatment.
stavudine neurologic side effect
Stavudine is a nucleoside analog still used in some developing countries for treatment of HIV. It produces a painful neuropathy which is not preventable.
docetaxel neurologic side effecrt
Docetaxel is a powerful chemotherapeutic agent which interferes with microtubule formation and disrupts axonal transport. Multiple supplements have been tried in an effort to prevent neuropathy from this agent, thus far without success.